Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 848–849 | Cite as

ASO Author Reflections: The Role of Tumor Size in the Prognosis of Anal Squamous Cell Carcinoma: A Validation on the New American Joint Committee on Cancer Subclassification of Stage IIA and B

  • Paolo Goffredo
  • Imran HassanEmail author
ASO Author Reflections
  • 24 Downloads

Notes

Disclosure

Paolo Goffredo and Imran Hassan have no conflicts of interest to disclose.

References

  1. 1.
    American Joint Committee on Cancer. American Joint Committee on Cancer Manual for Staging of Cancers. 3rd ed. American Joint Committee on Cancer; 1998.Google Scholar
  2. 2.
    Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30(35):4344–51.CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Goffredo P, Garancini M, Robinson TJ, Frakes J, Hoshi H, Hassan I. A national-level validation of the New American Joint Committee on Cancer 8th edition subclassification of stage IIA and B anal squamous cell cancer. Ann Surg Oncol. 2018;25(6):1654–60.Google Scholar
  4. 4.
    Glynne-Jones R, Nilsson PJ, Aschele C, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii10–20.Google Scholar
  5. 5.
    Benson AB 3rd, Venook AP, Al-Hawary MM, et al. Anal carcinoma, Version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN. 2018;16(7):852–71.Google Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of Iowa Hospitals and ClinicsIowa CityUSA

Personalised recommendations